LOC100289361: A Drug Target / Disease Biomarker (G100289361)
LOC100289361: A Drug Target / Disease Biomarker
LOC100289361 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the protein family known as the leucine-rich repeat (LRR) domain containing proteins, which are characterized by the presence of a specific repeat sequence in the protein sequence.
The LRR domain is known for its ability to interact with various molecules, including small molecules, ions, and other proteins. This interaction can lead to the regulation of various cellular processes, including cell signaling, DNA replication, and protein synthesis.
LOC100289361 has been identified as a potential drug target due to its involvement in several disease processes. One of the primary targets for LOC100289361 is the regulation of blood pressure, which is a critical factor in maintaining cardiovascular health.
Research has shown that LOC100289361 plays a role in the regulation of sodium and water intake, which are essential for maintaining proper blood pressure. The protein has been shown to interact with several sodium channels, including the N-type sodium channel. This interaction may contribute to the regulation of sodium intake and the maintenance of normal blood pressure.
Another potential target for LOC100289361 is the regulation of inflammation. The LRR domain is known for its ability to interact with various cytokines, which are proteins that play a key role in the regulation of inflammation. This interaction may contribute to the regulation of inflammation and the prevention of chronic inflammatory diseases.
LOC100289361 has also been shown to be involved in the regulation of cellular processes that are important for brain development and function. The protein has been shown to interact with several transcription factors that are involved in the regulation of brain development and the expression of various genes. This interaction may contribute to the regulation of brain development and the maintenance of normal brain function.
In conclusion, LOC100289361 is a protein that has been identified as a potential drug target due to its involvement in several disease processes. The LRR domain and its interaction with various molecules make it an attractive target for drug development. Further research is needed to fully understand the role of LOC100289361 in disease and to develop effective treatments.
Protein Name: Uncharacterized LOC100289361
More Common Targets
LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770 | LOC101060017 | LOC101060106 | LOC101060179 | LOC101060400 | LOC101060445 | LOC101060524 | LOC101060632 | LOC101448202 | LOC101593348 | LOC101926887 | LOC101926948 | LOC101926953 | LOC101926959 | LOC101926969 | LOC101927002 | LOC101927020 | LOC101927025 | LOC101927026
